Modelling the structural and reactivity landscapes of tucatinib with special reference to its wavefunction-dependent

Ali Alsalme1, T Pooventhiran2, Nabil Al-Zaqri1

  • 1Department of Chemistry, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.

Insights

Tucatinib, a drug for HER2-positive breast cancer, shows high stability and potential for repurposing against COVID-19 based on computational analysis. Further studies are recommended for drug repurposing to combat the pandemic.

Area of Science:

  • Computational chemistry and drug discovery.

Background:

  • HER2-type breast cancer is an aggressive malignancy.
  • Tucatinib is a newly approved medication for this condition.

Purpose of the Study:

  • To investigate the structural, reactivity, and electronic properties of Tucatinib using computational methods.
  • To explore the potential of Tucatinib for drug repurposing against COVID-19.

Main Methods:

  • Density Functional Theory (DFT) for geometry optimization.
  • Time-Dependent DFT (TD-DFT) for electronic excitations.
  • Molecular docking simulations for biological activity prediction.

Main Results:

  • Tucatinib exhibits inherent stability based on information entropy calculations.
  • Computational analysis revealed key intermolecular interactions and reactive sites.
  • Molecular docking against COVID-19 proteins yielded significant negative binding scores, indicating strong interactions.

Conclusions:

  • Tucatinib possesses favorable computational properties for its known application.
  • The drug demonstrates potential for repurposing in combating the COVID-19 pandemic due to strong predicted interactions with viral proteins.